Animal Rights (And Wrongs)

Let's give the animal rights movement due credit. Its highly visible efforts have contributed to a number of positive changes in the laboratory use of animals for purposes of assessing the safety and efficacy of pharmaceuticals, cosmetics, and other products: The housing and care of lab animals have improved greatly. The total number of animals used has declined drastically during the past several years. Today, in universities and industrial laboratories, committees vigilantly oversee the anima

Written byAlbert Kligman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Unfortunately, the movement has a downside that threatens to paralyze biomedical research.

Few researchers can look at the assertions and actions of the Washington-based People for the Ethical Treatment of Animals (PETA) without becoming enraged. The organization's overheated propaganda, its distortions of the truth, its intimidation of respected scientists, and various acts that border on guerrilla warfare have so alienated the group's opponents that rational dialogue seemingly has become impossible.

Passions run high on both sides, to the detriment of the whole research enterprise, whose triumphs in the last two decades alone are shining examples of the progress animal research has provided.

While researchers certainly have a compelling case and can cite numerous human diseases that have come under control through research on animals, the truths they reveal are cavalierly deflected by the animal rights zealots. And the scientists, with their cool rationalizations, are no match for PETA's ability to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies